• Now Available! Now Available!

        REQUEST DEMO

  • Now Available! Now Available!

    NOW AVAILABLE

    Learn more about the new HTG EdgeSeq Pan B-Cell Lymphoma Panel

    Learn More

  • Now Available! Now Available!
  • Now Available! Now Available!

    NOW AVAILABLE

    Learn more about the new HTG EdgeSeq Immune Response Panel

    Learn More

  • Now Available! Now Available!

    NOW AVAILABLE

    Learn more about HTG’s new Precision Immuno-Oncology Panel

    Learn More

 

USE HTG

Hear how HTG Molecular is committed to collaborating with our investigators around the globe to address key diagnostic and therapeutic questions that can eventually be translated to empower precision medicine at the local level.

As an example, at the ASCO 2019 Clinical Science Symposium, Dr. William from M.D. Anderson and Hospital BP in Sao Paulo Brazil presented an interesting body of work around the molecular landscape of oral neoplasias and the risk of progression to malignancy.

Learn More

A Revolution in Molecular Profiling

Our next-generation sequencing (NGS)-adapted chemistry and instrument platforms automate sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets from samples a fraction of the size required by competitive technologies, enabling customers to do more molecular profiling with less sample.

Learn More

 

HTG EdgeSeq Match Gene:Panel Connection Tool

Use our HTG EdgeSeq Match Gene:Panel Connection tool to connect your gene of interest to our specific assay. The HTG EdgeSeq panel gene names conform to the names curated by the HUGO Gene Nomenclature Committee part of the NCBI.  Aliases may or may not be found in this data bank.  The HUGO approved symbol can be found here.

We've added a new feature! Now you can quickly find all available HTG matching gene options using a partial match search. Please note: when inputting a search term, a hyphen may be required to return a match, e.g. miR-129. 

Gene:Assay Connection

Now Available

HTG EdgeSeq Pan B-Cell Lymphoma panel.  The newest addition to our RUO portfolio.  It is designed to provide molecular characterization of aggressive lymphomas by allowing researchers to measure the expression of genes associated with the lymphoma transcriptome.

  • Overcome sample input limitations using HTG's proprietary extraction-free chemistry and low sample input
  • Identify molecular sub-typing algorithms using HTG EdgeSeq Reveal software - a web-based biostatistical analysis tool
  • Compatibility with Illumina and Thermo Fisher Scientific NGS sequencers

 

News & Events

HTG Announces Board of Directors Transition

Timothy Johnson to Retire from the Board; Ann Hanham, Ph.D. Remains Lead Independent Director TUCSON, Ariz. , Jan. 19, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that Timothy

Keep Reading

HTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial Results

Preliminary full year 2020 unaudited revenue of $8.5 million Cash, cash equivalents and short-term marketable securities of $28.7 million as of December 31, 2020 TUCSON, Ariz. , Jan. 05, 2021 (GLOBE NEWSWIRE) –   HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose

Keep Reading

HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide Variants

TUCSON, Ariz. , Dec. 30, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has received notification of the issuance of Canadian patent number 2877729 for “Nuclease

Keep Reading

HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel

TUCSON, Ariz. , Dec. 18, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has signed up the first collaborator in its recently announced Early Access Program for its

Keep Reading

HTG Announces an Early Access Program for its Prototype Whole Transcriptome Panel

TUCSON, Ariz. , Dec. 08, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has launched an Early Access Program for its whole transcriptome panel using the HTG EdgeSeq

Keep Reading

HTG Announces One-for-Fifteen Reverse Stock Split

TUCSON, Ariz. , Nov. 23, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that as a result of its one-for-fifteen reverse stock split which became effective at 5:00 p.m.

Keep Reading

Careers at HTG

At HTG Molecular Diagnostics, Inc., we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

Featured Positions

Sr. Manager/Director Assay Development

New Careers

Director, Pharma Partnerships

Vice President, Pharma Partnerships

Commercial Lab Team Lead

Commercial Lab Technician

See All Careers


Resources

Find product information, specifications and gene lists here. 

Case Studies

Brochures

Gene Lists

Product Sheets

Tech Notes

Safety Data Sheets

Videos


Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Posters

Abstracts

Webinars

Peer Reviewed Publications

Editorials

Reviews


Support

Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or panels. 

Product Launch Files

User Manuals RUO

User Manuals CE-IVD

Package Inserts RUO

Package Inserts CE-IVD

Training Modules RUO

Training Modules CE-IVD

Deployer Software Downloads

HTG Software Downloads

Page last updated February 25, 2021

Ready to get started?

HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.

Get in Touch